THU-264 - High sustained virologic response rates in patients with chronic hepatitis C virus GT1, 2 or 3 infection following 16 weeks of MK-3682/grazoprevir/ruzasvir plus ribavirin after having failed 8 weeks of a triplet drug regimen (Part C of C-CREST-1 & 2)

• Published in: Journal of hepatology Vol. 66; no. 1; pp. S306 - S307
• Main Authors: Serfaty, L., Pianko, S., Ari, Z.B., Laursen, A.L., Hansen, J., Gane, E.J., Huang, H.-C., Jin, S., Bourque, J., Liu, H., Grandhi, A., Su, M., Gendrano, N., Fernsler, D., Dutko, F., Nguyen, B.-Y.T., Wahl, J., Barr, E., Yeh, W., Plank, R., Butterton, J.R.
• Format: Journal Article
• Language: English
• Published: Elsevier B.V 2017
• ISSN: 0168-8278; 1600-0641
• DOI: 10.1016/S0168-8278(17)30931-5